Amylyx Pharmaceuticals：Amylyx Pharmaceuticals
Amylyx Pharmaceuticals
Amylyx 完成1.35 億美元C 輪募資，持續研發神經退化性疾病 ...
https://geneonline.news
FDA 核准ALS 療法進度遲緩. 2017 年，脊髓側索硬化症藥物AMX0035 便取得FDA 認可的孤兒藥資格（Orphan Drug Desigantion），但此後核准進度 ...
Careers
https://www.amylyx.com
We are looking for mission-driven builders, thought-provokers, disruptors, audacious minds, and compassionate souls. Most of all, we're looking for the ones who ...
Investors
https://investors.amylyx.com
The Investor Relations website contains information about Amylyx Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial ...
Leadership Team
https://www.amylyx.com
Executive team · Debra Canner · Josh Cohen · James M. Frates · Tom Holmes · Justin Klee · Gina M. Mazzariello · Margaret Olinger · Patrick Yeramian, MD, MBA.
News
https://www.amylyx.com
From clinical trials to corporate announcements, we're proud to share our recent updates and progress with the community.
Our Company
https://www.amylyx.com
Amylyx is a global pharmaceutical company based in Cambridge, Massachusetts, that is dedicated to the discovery and development of potential treatments for ...
Pipeline
https://www.amylyx.com
We are committed to exploring the full potential of our existing and exploratory therapies and advancing our pipeline in an effort to support our mission of one ...
Press Releases - Investors
https://investors.amylyx.com
Amylyx Pharmaceuticals to Participate at the 6th Annual Evercore ISI HealthCONx Conference ... Amylyx Pharmaceuticals to Report Fourth Quarter and Full Year 2022 ...